: C4 Therapeutics upgraded to buy from hold at Stifel, with price target lifted to $12 from $2

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Generated by Feedzy